CXCL1 and leukemia: Ex vivo experiments from different research groups indicate that leukemia stimulation of primary BM-MSCs is able to specifically upregulate the expression of CCL2, CXCL10, CCL22, CXCL8, and CXCL1 [67,68,69,70].